COVID-19 Update

Combatting Future Viral Threats with Vaccine Advances

The COVID-19 pandemic has led to many changes in how pharmaceutical companies develop vaccines.

What’s Next for COVID-19 Vaccines and Variants?

More technologies and treatments are emerging for COVID-19—along with new variants.

Key Elements for Assay Transfer Success

Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers.

FDA Grants Fast Track Designation to Novavax’s COVID-19 Vaccine Candidate

November 10, 2020

The vaccine will enter into a Phase III clinical trial in the United States and Mexico by the end of November, which could potentially support global authorization and approval of the vaccine.

Pfizer: COVID-19 Vaccine Shows High Efficacy

November 09, 2020

Interim efficacy data suggests the Pfizer/BioNTech has an efficacy rate above 90%.

Protecting Intellectual Property for COVID-19 Innovations

November 06, 2020

Opposition to IP protection for COVID-19 vaccines, therapies, tests and other technologies may only prevent eradication and treatment of the disease.

Pandemic Response Lessons for Biopharma Companies

November 04, 2020

Biopharma can apply new manufacturing practices adopted during the COVID-19 pandemic to enhance bioprocessing.

Lonza to Manufacture AstraZeneca's COVID-19 Long-Acting Antibody Combination

November 03, 2020

The agreement will provide capacity for the manufacturing of AZD7442, currently being developed for the potential prevention and treatment of COVID-19, at Lonza's Portsmouth, NH site.

Novavax to Expand its Maryland Sites to Accommodate Rapid Company Growth

November 03, 2020

In the wake of its efforts to develop a COVID-19 vaccine candidate, the company has secured two additional properties in the Gaithersburg, MD area.

EDQM Releases Document on Recombinant Viral Vectored Vaccines for COVID-19

November 03, 2020

The document provides analytical strategy options for the control of recombinant viral vectored vaccines to support COVID-19 vaccine developers.

GMPs Guide COVID-19 Vaccine Manufacturing

November 03, 2020

Recent industry guidance aims to anchor rapid COVID-19 vaccine development in good manufacturing practice protocols.

COVID-19 Vaccine Distribution Raises Multiple Challenges

November 02, 2020

Experts fear confusion over allocation processes, cold-chain requirements, and IT systems needed to bring a COVID-19 vaccine to market.

COVID-19 Stresses EMA Resources

November 02, 2020

The agency is balancing a variety of important issues including the review of COVID-19 vaccines.